59886f44_NG_TO_TYPE_3_INTERFERON_FAMILY__0
[2] Clinical Trial Disclosures And Adverse Event Reporting [0] 
Exhibit I
CO-DEVELOPMENT/CO-PROMOTION AND LICENSE AGREEMENT RELATING TO TYPE-3 INTERFERON FAMILY
0